Monday, January 8, 2024 Novel Antibody-based Pathogen Detection Method Developed by NIAID Scientists The rapid DNA-RNA hybrid immunoassay developed by NIAID scientists was used to detect the RNA of Bacillus anthracis, shown here as a lateral flow test. (Credit: NIAID/Dr. Ankur Bothra) A study of a novel lab test found it detected the RNA of several pathogens, including Bacillus anthracis, Toxoplasma gondii and SARS-CoV-2. NIAID researchers developed the test, a rapid DNA-RNA hybrid capture immunoassay that uses the S9.6 antibody to detect the RNA of pathogens. In a new article in Scientific Reports, the authors explain that the assay is sensitive, versatile, and requires fewer resources than the nucleic acid-based tests often used as diagnostic tools for clinical and public health purposes. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107